Trial intelligence / Profile preview

ESP Block vs PVB for Breast Surgery

NCT03471442Completed

Sponsor
University of Alberta
Start
May 2018
Primary completion
Apr 2021
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by University of Alberta. Primary endpoint: Dermatomal spread of sensory blockade at 30 months. Started May 2018; status: completed.

Beyond the preview

Go deeper on NCT03471442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03471442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call